Viemed Healthcare (VMD) CMO reports RSU and phantom unit vesting, tax share withholding

Rhea-AI Filing Summary

Viemed Healthcare, Inc. Chief Medical Officer and director William Frazier reported equity award vesting and related share transactions. On January 29, 2026, 2,334 Restricted Stock Units converted into 2,334 common shares, and 778 phantom share units converted into 778 common shares, both at an exercise price of $0 per share.

To cover tax obligations from the RSU vesting, 802 common shares were withheld and disposed of at $7.48 per share, based on the closing market price on January 29, 2026. After these transactions and related dispositions, Frazier beneficially owned 73,214 common shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frazier William

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/29/2026		M		2,334	A	(1)	74,016	D
Common Shares	01/29/2026		F		802(2)	D	$7.48(3)	73,214	D
Common Shares	01/29/2026		M		778	A	(4)	73,992	D
Common Shares	01/29/2026		D		778	D	$7.48(3)	73,214	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/29/2026		M			2,334	(5)	01/29/2027	Common Shares	2,334	$0	2,334	D
Phantom Share Units	(4)	01/29/2026		M			778	(6)	01/29/2027	Common Shares	778	$0	778	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 29, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Viemed Healthcare (VMD) report for William Frazier?

Viemed Healthcare reported that Chief Medical Officer William Frazier had RSUs and phantom share units vest into common shares, with some shares withheld for taxes. These routine equity award events resulted in updated direct beneficial ownership figures in the company’s common shares.

How many Viemed Healthcare (VMD) RSUs vested for William Frazier on January 29, 2026?

On January 29, 2026, 2,334 Restricted Stock Units vested for William Frazier, each converting into one common share. This followed the original grant made on January 29, 2024, which vests in three equal annual installments starting on the first anniversary.

What are phantom share units in the Viemed Healthcare (VMD) Form 4?

The phantom share units are cash-settled awards economically equivalent to one common share. On January 29, 2026, 778 phantom share units vested, leading to an acquisition of 778 common shares and a simultaneous cash settlement back to the company for those underlying shares.

Why were some Viemed Healthcare (VMD) shares sold at $7.48 in this Form 4 filing?

The Form 4 shows 802 common shares disposed of at $7.48 per share to satisfy Frazier’s tax withholding obligations arising from RSU vesting. The per-share value reflects the closing market price of Viemed Healthcare common shares on January 29, 2026.

How many Viemed Healthcare (VMD) shares does William Frazier own after these transactions?

After all reported transactions on January 29, 2026, William Frazier directly beneficially owned 73,214 Viemed Healthcare common shares. This total reflects RSU and phantom share vesting, as well as the shares withheld and disposed of to cover tax obligations.

What vesting schedule applies to William Frazier’s Viemed Healthcare RSUs and phantom units?

The RSUs and phantom share units reported were granted on January 29, 2024 and vest in three equal annual installments. Vesting begins on the first anniversary of the grant date, leading to the January 29, 2026 vesting events disclosed in this Form 4.